ClinicalTrials.gg
RecruitingNCT07292389Updated Mar 31, 2026

Examining Valence-based Effects in Self-Monitoring Feedback Messages

An interventional study of Positive Reinforcement and Positive Reinforcement + Areas for Change in Obesity & Overweight and Obesity (Disorder), sponsored by University of Virginia. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by University of Virginia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
127
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 23 studies in Obesity by University of Virginia — 7 open to participants now, 10 under way, 1 of them phase 3. Obesity · University of Virginia.

Planned enrollment
5th of 20
127 · median 23
Started
2026
with 2 others
No phase
13 of 23
3 open now
Registered
21st of 23
by date

Among the 23 studies in Obesity by University of Virginia, this one is the 5th largest by planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2026, is one of 13 with no phase, and was the 21st registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

7 of the 23 studies in Obesity by University of Virginia are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Obesity by University of Virginia, or all of them as a file.
02

Study summary

The purpose of this research study is to learn how to identify the most effective ways to provide weekly feedback on participants' progress toward intervention goals during a weight loss program.

Read the detailed description

This micro-randomized factorial trial is designed to provide information about how to optimize self-monitoring feedback within a behavioral weight management intervention. All participants will attend a "Weight Loss 101" session that covers foundational weight loss education and behavioral skills training. During this session, they will also learn how to use study-provided tools to track their dietary intake, physical activity, and weight.

Each weekly feedback message will be composed by a trained interventionist. Participants will be randomized each week to one of the two conditions to examine how the tone and composition of feedback messages impact participant behaviors and weight loss.

The main questions that this study aims to answer are:

  • How does the composition of supportive feedback and ideas for potential changes in dietary or physical activity behaviors impact weight loss.
  • How is this feedback affected by individual or contextual factors?
03

Conditions studied

  • Obesity & Overweight
  • Obesity (Disorder)

Keywords

  • weight loss
  • self-monitoring
  • smartphone app
  • lifestyle intervention
  • digital health
  • physical activity
  • dietary change
  • e-scale
  • wearables
  • activity monitor
  • behavior change
  • self-monitor activity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age greater than or equal to 18 years
  • greater than or equal to 25.0 kg/m2
  • Weight less than or equal to 175 kg (due to scale limit)
  • Own a smartphone compatible with Fitbit (e.g., an Apple iPhone running iOS 16.4 or higher or Android smartphone running Android 11 or higher) with a cellular and data plan

Exclusion criteria

Exclusion Criteria:

  • Weight greater than 175 kg (due to a weight limit of the study-provided scale)
  • Smartphone device owned deemed incompatible with the Fitbit App
  • History of bariatric surgery or plans to obtain bariatric surgery during the study period
  • Current use of weight loss medications, or use of weight loss medications in the 6 months prior to initial pre-screening
  • Currently participating in a weight-loss program
  • Weight loss of greater than or equal to 10 lbs in the 6 months prior to initial pre-screening
  • Physical limitations that prevent walking at a brisk pace for at least 10 minutes without stopping
  • Use of a pacemaker or other implanted medical device
  • Currently pregnant
  • Currently breastfeeding
  • Less than 1-year post-partum
  • Plans to become pregnant within the study period
  • Lack of written confirmation that the potential participant has discussed study participation with their physician if they have been diagnosed with diabetes, hypertension, or has have a history of coronary heart disease
  • One or more study participants living in the household (enrollment limited to one participant per household)
  • Medical conditions that contraindicate weight loss or prevent completion of the study (e.g., current diagnosis of cancer or terminal illness, dementia, etc.)
  • Recent (in the past 6 months) changes in medications that affect weight
  • Self-reported eating disorder within past 5 years
  • Unable to complete the 17-week study (due to plans to relocate during the study period, etc.)
  • Unable or unwilling to provide
  • Unable to read English at the 5th grade level
  • Unwilling to accept random assignment
  • Unable or unwilling to download the study smartphone application, wear the physical activity monitor, or use the study e-scale
  • Failure to complete baseline assessment measures
  • Failure to complete at least 4 out of 6 days of self-monitoring dietary and weight self-monitoring during the behavioral run-in period
  • Any other condition(s) which, in the opinion of the Principal Investigator, would adversely affect participation in the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
127 participants (estimated)

Study arms

  • Experimental
    Self Monitoring Feedback

    Participants in this study will complete a 60-minute "Weight Loss 101" session and use study-provided tools to record their daily food intake, physical activity, and weight. After a one-week run-in period, they will begin receiving weekly feedback messages. The content and emphasis of these messages will differ between 2 conditions: positive reinforcement vs. positive reinforcement + areas for change.

    Behavioral: Positive Reinforcement · Behavioral: Positive Reinforcement + Areas for Change

Interventions

  • BehavioralPositive Reinforcement

    Feedback composed by a study interventionist that focuses exclusively on positively reinforcing the participant's progress toward achieving their goals.

  • BehavioralPositive Reinforcement + Areas for Change

    Feedback provided by a study interventionist that combines positive reinforcement of the participant's progress with constructive guidance on areas for improvement to support successful goal attainment.

06

What researchers measure

Primary outcomes

  1. Weight change

    Mixed-effects models will be used to investigate the impact of each feedback condition on our primary outcome of weight change. Fitted model estimates will be used to calculate the slope of weight change from day 1 (the day a feedback message is delivered) through day 7 of each week. Positive slopes indicate weight gain, while negative slopes indicate weight loss.

    Time frame: 7 days

Secondary outcomes

  1. Frequency of self-monitoring weight

    Frequency of self-monitoring weight will be defined as the number of days (0-7) in the week following a feedback message (from day 1, the day that a feedback message is received, to day 7) in which the participant records a valid (non-outlier) e-scale weight.

    Time frame: 7 days

  2. Frequency of self-monitoring dietary intake

    A valid "day" of dietary self-monitoring will be defined as ≥ 800 kcal recorded, consistent with prior research. Frequency is calculated as the number of valid days (0-7) recorded the week after a feedback message is delivered (from day 1, the day that a feedback message is received, to day 7).

    Time frame: 7 days

  3. Total caloric intake

    Total caloric intake will be calculated by summing calories consumed during the week following a feedback message is received (from day 1, the day that a feedback message is received, to day 7)

    Time frame: 7 days

  4. Calorie goal attainment

    Calorie goal attainment for each day during the week after a feedback message is received (from day 1, the day a feedback message is received, to day 7). Calorie goal attainment will be calculated as \[TOTAL KCAL INTAKE FOR THE DAY\] - \[CALORIE GOAL\]. Daily difference scores for the 7 days will be averaged across the week to determine overall adherence to the caloric intake goal.

    Time frame: 7 days

  5. Frequency of self-monitoring physical activity

    Frequency of self-monitoring physical activity will be defined as the number of "valid" days (0-7) of Fitbit use the week after a feedback message is received (from day 1, the day that a feedback message is received, to day 7).

    Time frame: 7 days

  6. Physical activity minutes

    Total minutes of physical activity will be calculated by summing each days' total "active zone minutes" during the week after a feedback message is delivered (from day 1, the day that a feedback message is received, to day 7)

    Time frame: 7 days

  7. Physical activity goal attainment

    Physical activity goal attainment for each day of the week after a feedback message is received (from day 1, the day that a feedback message is received, to day 7) will be calculated as \[TOTAL PHYSICAL ACTIVITY MINUTES\] - \[PHYSICAL ACTIVITY GOAL\]. Daily difference scores will be averaged over the week to assess overall adherence to the physical activity goal during that study week.

    Time frame: 7 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual-level participant data will be de-identified and made available at the time of publication of peer-reviewed manuscript(s) based on the data. Study data will be shared via the Zenodo data repository at https://zenodo.org/. Analytic code will be made publicly available via Supplementary files for any publications and/or via Zenodo through a Zenodo-GitHub link. Study protocol, informed consent form, statistical analysis plan will also be available to be shared via clinicaltrials.gov.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: De-identified, individual-level participant data will be made available at the time of publication of peer-reviewed manuscript(s) based on the data.

Access criteria: Data will be made available via the Zenodo data repository (https://zenodo.org).

Data sharing details ↗ · zenodo.org

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for May 2027, 14 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 14 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2025
First posted
Dec 18, 2025
StartActual
Mar 23, 2026
Primary completionEst.
May 2027
CompletionEst.
Jun 2027
Last update
Mar 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07292389
Responsible party
Rebecca A. Krukowski (Principal Investigator, University of Virginia) — Principal investigator
First posted
Dec 18, 2025
Start date
Mar 23, 2026
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 31, 2026

Study contacts

Maddie Glover, B.S.
Contact
ktg7zr@virginia.edu
4342432387
Teace Markwalter, M.P.H., CHES
Contact
bdwcp@virginia.edu
540-239-6283
Becca Krukowski, Ph.D.
principal investigator · University of Virginia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion